Trials / Completed
CompletedNCT00332540
Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 520 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of Bimatoprost/Timolol Fixed Combination in patients with glaucoma or ocular hypertension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bimatoprost/timolol fixed combination |
Timeline
- Start date
- 2001-08-01
- Primary completion
- 2003-08-01
- Completion
- 2003-08-01
- First posted
- 2006-06-01
- Last updated
- 2011-05-30
Locations
2 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00332540. Inclusion in this directory is not an endorsement.